effects chocolate cocoa flavan num ols cardiovascular health systematic review meta-analysis randomized trials pubmed ncbi abstract background substantial interest chocolate flavan num ols prevention cardiovascular disease cvd objective objective systematically review effects chocolate cocoa flavan num ols major cvd risk factors design searched medline embase cochrane databases randomized controlled trials rcts chocolate cocoa flavan num ols contacted authors additional data conducted duplicate assessment study inclusion data extraction validity random-effects meta-analyses results included num acute short-term chronic num wk rcts comprised num participants insulin resistance homa-ir num num ci num num improved chocolate cocoa due significant reductions serum insulin flow-mediated dilatation fmd improved chronic num num ci num num acute num num ci num num intakes effects homa-ir fmd remained stable sensitivity analyses observed reductions diastolic blood pressure bp num mm hg num ci num num mm hg arterial pressure num mm hg num ci num num mm hg marginally significant effects ldl num mmol/l num ci num num mmol/l hdl num mmol/l num ci num num mmol/l cholesterol chocolate cocoa improved fmd dose consumed doses num mg epicatechin/d resulted greater effects systolic diastolic bp grade grading recommendations assessment development evaluation tool assess quality evidence strength recommendations suggested low moderate-quality evidence beneficial effects suggestion negative effects strength evidence lowered due unclear reporting allocation concealment dropouts missing data outcomes heterogeneity biomarker results studies conclusions found consistent acute chronic benefits chocolate cocoa fmd previously unreported promising effects insulin homa-ir larger longer-duration independently funded trials required confirm potential cardiovascular benefits cocoa flavan num ols 
